NICE endorses breast-cancer metastasis analyzer from Sysmex

08/8/2013 | Clinica (subscription required)

Sysmex has received endorsement from the U.K.'s National Institute for Health and Care Excellence for its RD-100i OSNA technology. The recommendation applies for use of the device in diagnosing sentinel lymph node metastases in patients undergoing initial breast cancer surgery.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA